And for all those tired of waiting for the company to announce what is clearly market sensitive information and now freely available on the internet, here is the CPT outcome.http://www.ama-assn.org/resources/doc/cpt/summary-of-panel-actions-feb2012.pdfUnless I am mistaken it is item 89 and they were awarded a category 3 which is what was expected.Now let's get the capital raising out of the way... until the next one.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
